Skip to main content

Advertisement

Log in

The Nelson's syndrome... revisited

  • Published:
Pituitary Aims and scope Submit manuscript

Abstract

Adrenalectomy is a radical therapeutic approach to control hypercortisolism in some patients with Cushing's disease. However it may be complicated by the Nelson's syndrome, defined by the association of a pituitary macroadenoma and high ACTH secretion after adrenalectomy. This definition has not changed since the end of the fifties. Today the Nelson's syndrome must be revisited with new to criteria using more sensitive diagnostic tools, especially the pituitary magnetic resonance imaging.

In this paper we will review the pathophysiological aspects of corticotroph tumor growth, with reference to the impact of adrenalectomy. The main epidemiological data on the Nelson's syndrome will be presented.

More importantly, we will propose a new pathophysiological and practical approach to this question which attempts to evaluate the Corticotroph Tumor Progression after adrenalectomy, rather than to diagnose the Nelson's syndrome. We will discuss the consequences for the management of Cushing's disease patients after adrenalectomy, and will also draw some perspectives.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Nelson DH, Meakin JW, Dealy JB Jr, Matson DD, Emerson K Jr, Thorn GW. ACTH-producing tumor of the pituitary gland. N Engl J Med 1958;259(4):161–164.

    CAS  PubMed  Google Scholar 

  2. Salassa RM, Kearns TP, Kernohan JW, Sprague RG, Maccarty CS. Pituitary tumors in patients with Cushing's syndrome. J Clin Endocrinol Metab 1959;19:1523–1539.

    CAS  PubMed  Google Scholar 

  3. Montgomery DA, Welbourn RB, McCaughey WT, Gleadhill CA. Pituitary tumours manifested after adrenalectomy for Cushing's syndrome. Lancet 1959;2:707–710.

    CAS  PubMed  Google Scholar 

  4. Glenn F, Karl RC, Horwith M. The surgical treatment of Cushing's syndrome. Ann Surg 1958;148(3):365–374.

    CAS  PubMed  Google Scholar 

  5. Rees JR, Zilva JF. Diabetes insipidus complicating total adrenalectomy. J Clin Pathol. 1959;12:530–534.

    CAS  PubMed  Google Scholar 

  6. Cushing H. The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). Bull John Hopkins Hosp 1932;50:137–195.

    Google Scholar 

  7. Bertagna X, Raux-Demay MC, Guilhaume B et al. Cushing's Disease. In The Pituitary, S. Melmed, ed, 2nd ed. Blackwell 2002: pp 496–560.

  8. de Keyzer, Bertagna X, Lenne F, et al. Proopiomelanocortin gene expression in ACTH secreting non-pituitary tumors. J Clin Invest 1985;76:1892–1898.

    CAS  PubMed  Google Scholar 

  9. Raffin-Sanson ML, de Keyzer Y, Bertagna X. Proopiomelanocortin, a polypeptide precursor with multiple functions: From physiology to pathological conditions. Eur J Endocrinol 2003;149(2):79–90. Review

    Article  CAS  PubMed  Google Scholar 

  10. Dahia PL, Grossman AB. The molecular pathogenesis of corticotroph tumors. Endocr Rev 1999;20(2):136–155.

    Article  CAS  PubMed  Google Scholar 

  11. de Keyzer Y, Rene P, Lenne F, Auzan C, Clauser E, Bertagna X. V3 vasopressin receptor and corticotropic phenotype in pituitary and nonpituitary tumors.Horm Res 1997;47(4–6):259–262. Review

    PubMed  Google Scholar 

  12. Herman V, Fagin J, Gonsky R, Kovacs K, Melmed S. Clonal origin of pituitary adenomas. J Clin Endocrinol Metab 1990;71(6):1427–1433.

    CAS  PubMed  Google Scholar 

  13. Gicquel C, Le Bouc Y, Luton JP, Girard F, Bertagna X. Monoclonality of corticotroph macroadenomas in Cushing's disease. J Clin Endocrinol Metab 1992;75(2):472–475.

    Article  CAS  PubMed  Google Scholar 

  14. Wolfsen AR, Odell WD. The dose-response relationship of ACTH and cortisol in Cushing's disease. Clin Endocrinol (Oxf) 1980;12(6):557–568.

    CAS  Google Scholar 

  15. Suda T, Tozawa F, Dobashi I, Horiba N, Ohmori N, Yamakado M, Yamada M, Demura H. Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro. J Clin Invest 1993;92(6):2790–2795.

    CAS  PubMed  Google Scholar 

  16. Resetic J, Reiner Z, Ludecke D, Riznar-Resetic V, Sekso M. The effects of cortisol, 11-epicortisol, and lysine vasopressin on DNA and RNA synthesis in isolated human adrenocorticotropic hormone-secreting pituitary tumor cells. Steroids 1990;55(3):98–100.

    Article  CAS  PubMed  Google Scholar 

  17. Dahia PL, Honegger J, Reincke M, et al. Expression of glucocorticoid receptor gene isoforms in corticotropin-secreting tumors. J Clin Endocrinol Metab 1997;82(4):1088–1093.

    Article  CAS  PubMed  Google Scholar 

  18. Nolan LA, Levy A. Temporally sensitive trophic responsiveness of the adrenalectomized rat anterior pituitary to dexamethasone challenge: Relationship between mitotic activity and apoptotic sensitivity. Endocrinology 2003;144(1):212–219.

    Article  CAS  PubMed  Google Scholar 

  19. Karl M, Von Wichert G, Kempter E, et al. Nelson's syndrome associated with a somatic frame shift mutation in the glucocorticoid receptor gene. J Clin Endocrinol Metab 1996;81(1):124–129.

    Article  CAS  PubMed  Google Scholar 

  20. Huizenga NA, de Lange P, Koper JW, et al. Human adrenocorticotropin-secreting pituitary adenomas show frequent loss of heterozygosity at the glucocorticoid receptor gene locus. J Clin Endocrinol Metab 1998;83(3):917–921.

    Article  CAS  PubMed  Google Scholar 

  21. Carey RM, Varma SK, Drake CR Jr., et al. Ectopic secretion of corticotropin-releasing factor as a cause of Cushing's syndrome. A clinical, morphologic, and biochemical study. N Engl J Med 1984;311(1):13–20.

    CAS  PubMed  Google Scholar 

  22. Gertz BJ, Contreras LN, McComb DJ, Kovacs K, Tyrrell JB, Dallman MF. Chronic administration of corticotropin-releasing factor increases pituitary corticotroph number. Endocrinology 1987;120(1):381–388.

    CAS  PubMed  Google Scholar 

  23. Stenzel-Poore MP, Cameron VA, Vaughan J, Sawchenko PE, Vale W. Development of Cushing's syndrome in corticotropin-releasing factor transgenic mice. Endocrinology 1992;130(6):3378–3386.

    Article  CAS  PubMed  Google Scholar 

  24. de Keyzer Y, Rene P, Beldjord C, Lenne F, Bertagna X. Overexpression of vasopressin (V3) and corticotrophin-releasing hormone receptor genes in corticotroph tumours. Clin Endocrinol (Oxf) 1998;49(4):475–482.

    Google Scholar 

  25. Dieterich KD, Gundelfinger ED, Ludecke DK, Lehnert H. Mutation and expression analysis of corticotropin-releasing factor 1 receptor in adrenocorticotropin-secreting pituitary adenomas. J Clin Endocrinol Metab 1998;83(9):3327-3331.

    Article  PubMed  Google Scholar 

  26. McNicol AM, Carbajo-Perez E. Aspects of anterior pituitary growth, with special reference to corticotrophs. Pituitary 1999;1(34):257–268.

    CAS  PubMed  Google Scholar 

  27. Wynn PC, Harwood JP, Catt KJ, Aguilera G. Regulation of corticotropin-releasing factor (CRF) receptors in the rat pituitary gland: Effects of adrenalectomy on CRF receptors and corticotroph responses. Endocrinology 1985;116(4):1653–1659.

    CAS  PubMed  Google Scholar 

  28. Sakai K, Horiba N, Sakai Y, Tozawa F, Demura H, Suda T. Regulation of corticotropin-releasing factor receptor messenger ribonucleic acid in rat anterior pituitary. Endocrinology 1996;137(5):1758–1763.

    Article  CAS  PubMed  Google Scholar 

  29. van Wijk PA, van Neck JW, Rijnberk A, Croughs RJ, Mol JA. Proliferation of the murine corticotropic tumour cell line AtT20 is affected by hypophysiotrophic hormones, growth factors and glucocorticoids. Mol Cell Endocrinol 1995;111(1):13–19.

    PubMed  Google Scholar 

  30. Nagesser SK, van Seters AP, Kievit J, Hermans J, Krans HM, van de Velde CJ. Long-term results of total adrenalectomy for Cushing's disease. World J Surg 2000;24(1):108–113.

    Article  CAS  PubMed  Google Scholar 

  31. Barnett AH, Livesey JH, Friday K, Donald RA, Espiner EA. Comparison of preoperative and postoperative ACTH concentrations after bilateral adrenalectomy in Cushing's disease. Clin Endocrinol (Oxf) 1983;18(3):301–305.

    CAS  Google Scholar 

  32. Kelly WF, MacFarlane IA, Longson D, Davies D, Sutcliffe H. Cushing's disease treated by total adrenalectomy: Long-term observations of 43 patients. Q J Med 1983;52(206):224–231.

    CAS  PubMed  Google Scholar 

  33. Streeten DH, Anderson GHJ. Endocrine Society Meeting 1994:abstract 44c.

  34. Chapuis Y, Pitre J, Conti F, Abboud B, Pras-Jude N, Luton JP. Role and operative risk of bilateral adrenalectomy in hypercortisolism. World J Surg 1996;20(7):775–779; discussion 779–780.

    CAS  PubMed  Google Scholar 

  35. Kasperlik-Zaluska AA, Nielubowicz J, Wislawski J, et al. Nelson's syndrome: Incidence and prognosis. Clin Endocrinol (Oxf) 1983;19(6):693–698.

    CAS  Google Scholar 

  36. Kemink L, Pieters G, Hermus A, Smals A, Kloppenborg P. Patient's age is a simple predictive factor for the development of Nelson's syndrome after total adrenalectomy for Cushing's disease. J Clin Endocrinol Metab 1994;79(3):887–889.

    Article  CAS  PubMed  Google Scholar 

  37. Manolas KJ, Farmer HM, Wilson HK, et al. The pituitary before and after adrenalectomy for Cushing's syndrome. World J Surg 1984;8(3):374–387.

    Article  CAS  PubMed  Google Scholar 

  38. Moore TJ, Dluhy RG, Williams GH, Cain JP. Nelson's syndrome: Frequency, prognosis, and effect of prior pituitary irradiation. Ann Intern Med 1976;85(6):731–734.

    CAS  PubMed  Google Scholar 

  39. Watson RG, van Heerden JA, Northcutt RC, Grant CS, Ilstrup DM. Results of adrenal surgery for Cushing's syndrome: 10 years' experience. World J Surg 1986;10(4):531–538.

    Article  CAS  PubMed  Google Scholar 

  40. Sonino N, Zielezny M, Fava GA, Fallo F, Boscaro M. Risk factors and long-term outcome in pituitary-dependent Cushing's disease. J Clin Endocrinol Metab 1996;81(7):2647–2652.

    Article  CAS  PubMed  Google Scholar 

  41. Welbourn RB, Montgomery DA, Kennedy TL. The natural history of treated Cushing's syndrome. Br J Surg 1971;58(1):1–16.

    CAS  PubMed  Google Scholar 

  42. Grabner P, Hauer-Jensen M, Jervell J, Flatmark A. Long-term results of treatment of Cushing's disease by adrenalectomy. Eur J Surg 1991;157(8):461–464.

    CAS  PubMed  Google Scholar 

  43. Bennett AH, Cain JP, Dluhy RG, Tynes WV, Harrison JH, Thorn GW. Surgical treatment of adrenocortical hyperplasia: 20-year experience. J Urol 1973;109(3):321–324.

    CAS  PubMed  Google Scholar 

  44. Moreira AC, Castro M, Machado HR. Longitudinal evaluation of adrenocorticotrophin and beta-lipotrophin plasma levels following bilateral adrenalectomy in patients with Cushing's disease. Clin Endocrinol (Oxf) 1993;39(1):91–96.

    CAS  Google Scholar 

  45. Jenkins PJ, Trainer PJ, Plowman PN, et al. The long-term outcome after adrenalectomy and prophylactic pituitary radiotherapy in adrenocorticotropin-dependent Cushing's syndrome. J Clin Endocrinol Metab 1995;80(1):165–171.

    Article  CAS  PubMed  Google Scholar 

  46. Pereira MA, Halpern A, Salgado LR, et al. A study of patients with Nelson's syndrome. Clin Endocrinol (Oxf) 1998;49(4):533–539.

    Article  CAS  Google Scholar 

  47. Thomas CG, Jr., Smith AT, Benson M, Griffith J. Nelson's syndrome after Cushing's disease in childhood: A continuing problem. Surgery 1984;96(6):1067–1077.

    PubMed  Google Scholar 

  48. Imai T, Funahashi H, Tanaka Y, et al. Adrenalectomy for treatment of Cushing syndrome: Results in 122 patients and long-term follow-up studies. World J Surg 1996;20(7):781–786; discussion 786–787.

    Article  CAS  PubMed  Google Scholar 

  49. McCance DR, Russell CF, Kennedy TL, Hadden DR, Kennedy L, Atkinson AB. Bilateral adrenalectomy: Low mortality and morbidity in Cushing's disease. Clin Endocrinol (Oxf) 1993;39(3):315–321.

    CAS  Google Scholar 

  50. Cohen KL, Noth RH, Pechinski T. Incidence of pituitary tumors following adrenalectomy. A long-term follow-up study of patients treated for Cushing's disease. Arch Intern Med 1978;138(4):575–579.

    CAS  PubMed  Google Scholar 

  51. Ernest I, Ekman H. Adrenalectomy in Cushing's disease. A long-term follow-up. Acta Endocrinol Suppl (Copenh) 1972;160:3–41.

    CAS  Google Scholar 

  52. Hopwood NJ, Kenny FM. Incidence of Nelson's syndrome after adrenalectomy for Cushing's disease in children: Results of a nationwide survey. Am J Dis Child 1977;131(12):1353–1356.

    CAS  PubMed  Google Scholar 

  53. Krieger DT, Samojlik E, Bardin CW. Cortisol and androgen secretion in a case of Nelson's syndrome with paratesticular tumors: Response to cyproheptadine therapy. J Clin Endocrinol Metab 1978;47(4):837–844.

    CAS  PubMed  Google Scholar 

  54. Baranetsky NG, Zipser RD, Goebelsmann U, et al. Adrenocorticotropin-dependent virilizing paraovarian tumors in Nelson's syndrome. J Clin Endocrinol Metab 1979;49(3):381–386.

    CAS  PubMed  Google Scholar 

  55. Ntalles K, Kostoglou-Athanassiou I, Georgiou E, Ikkos D. Paratesticular tumours in a patient with Nelson's syndrome. Horm Res 1996;45(6):291–294.

    CAS  PubMed  Google Scholar 

  56. Shekarriz M, Schneider C, Sabanegh E, Kempter F, Waldherr R. Excessive testosterone production in a patient with Nelson syndrome and bilateral testicular tumors. Urol Int 1996;56(3):200–203.

    CAS  PubMed  Google Scholar 

  57. Johnson RE, Scheithauer B. Massive hyperplasia of testicular adrenal rests in a patient with Nelson's syndrome. Am J Clin Pathol 1982;77(4):501–507.

    CAS  PubMed  Google Scholar 

  58. Mahmoud-Ahmed AS, Suh JH. Radiation therapy for Cushing's disease: A review. Pituitary 2002;5(3):175–180.

    Article  CAS  PubMed  Google Scholar 

  59. Vella A, Thompson GB, Grant CS, van Heerden JA, Farley DR, Young WF Jr. Laparoscopic adrenalectomy for adrenocorticotropin-dependent Cushing's syndrome. J Clin Endocrinol Metab 2001;86(4):1596–1599.

    Article  CAS  PubMed  Google Scholar 

  60. van der Hoek J, Waaijers M, van Koetsveld PM, Sprij-Mooij D, Feelders RA, Schmid HA, Schoeffter P, Hoyer D, Cervia D, Taylor JE, Culler MD, Lamberts SW, Hofland LJ. Distinct functional properties of native somatostatin receptor subtype 5 compared with subtype 2 in the regulation of ACTH release by corticotroph tumor cells. Am J Physiol Endocrinol Metab 2005 March 15

  61. Paez-Pereda M, Kovalovsky D, Hopfner U, Theodoropoulou M, Pagotto U, Uhl E, Losa M, Stalla J, Grubler Y, Missale C, Arzt E, Stalla GK. Retinoic acid prevents experimental Cushing syndrome. J Clin Invest 2001;108(8):1123–1131.

    Article  CAS  PubMed  Google Scholar 

  62. Heaney AP, Fernando M, Yong WH, Melmed S. Functional PPAR-gamma receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas.Nat Med 2002;8(11):1281–1287. Epub 2002 Oct 15.

    Article  CAS  Google Scholar 

  63. Schacke H, Schottelius A, Docke WD, Strehlke P, Jaroch S, Schmees N, Rehwinkel H, Hennekes H, Asadullah K. Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects. Proc Natl Acad Sci USA 2004; 101(1):227–232. Epub 2003 Dec 23.

    Article  Google Scholar 

  64. Juliani G, Avataneo T, Potenzoni F, Sorrentino T. [CT and MR compared in the study of hypophysis]. Radiol Med (Torino) 1989;77(1-2):51–64.

    CAS  Google Scholar 

  65. Johnson MR, Hoare RD, Cox T, et al. The evaluation of patients with a suspected pituitary microadenoma: Computer tomography compared to magnetic resonance imaging. Clin Endocrinol (Oxf) 1992;36(4):335–338.

    CAS  Google Scholar 

  66. Vest-Courtalon C, Ravel A, Perez N, et al. Pituitary gland MRI and Cushing disease: Report of 14 operated patients. J Radiol 2000;81(7):781–786.

    CAS  PubMed  Google Scholar 

  67. Melmed S. Mechanisms for pituitary tumorigenesis: The plastic pituitary. J Clin Invest 2003;112(11):1603–1618. Review.

    Article  CAS  PubMed  Google Scholar 

  68. Heaney AP, Melmed SR. Molecular targets in pituitary tumours. Nat Rev Cancer 2004;4(4):285–295. Review.

    Article  CAS  PubMed  Google Scholar 

  69. Evans CO, Young AN, Brown MR, Brat DJ, Parks JS, Neish AS, Oyesiku NM. Novel patterns of gene expression in pituitary adenomas identified by complementary deoxyribonucleic acid microarrays and quantitative reverse transcription-polymerase chain reaction. J Clin Endocrinol Metab 2001;86(7):3097–3107.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xavier Bertagna.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Assié, G., Bahurel, H., Bertherat, J. et al. The Nelson's syndrome... revisited. Pituitary 7, 209–215 (2004). https://doi.org/10.1007/s11102-005-1403-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11102-005-1403-y

Keywords

Navigation